Welcome to LookChem.com Sign In|Join Free
  • or
Ethyl 4-hydroxy-3,5-di-tert-butylphenylacetate is a chemical compound with the molecular formula C16H24O3. It is a derivative of phenylacetate, featuring a hydroxyl group at the 4-position and two tert-butyl groups at the 3 and 5 positions. ethyl 4-hydroxy-3,5-di-tert-butylphenylacetate is known for its antioxidant properties, which make it useful in various industrial applications, particularly in the stabilization of polymers and plastics to prevent degradation caused by oxidation. It is also used as a UV stabilizer in the production of certain types of plastics and resins, helping to extend their lifespan and maintain their integrity under exposure to sunlight. The compound's structure provides it with the ability to scavenge free radicals, thereby protecting materials from oxidative stress.

6386-40-9

Post Buying Request

6386-40-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6386-40-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 6386-40-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,3,8 and 6 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 6386-40:
(6*6)+(5*3)+(4*8)+(3*6)+(2*4)+(1*0)=109
109 % 10 = 9
So 6386-40-9 is a valid CAS Registry Number.

6386-40-9Relevant academic research and scientific papers

Inhibitors of lipoprotein(a) assembly

Sexton, Karen E.,Lee, Helen T.,Massa, Mark,Padia, Janak,Patt, William C.,Liao, Peggy,Pontrello, Jason K.,Roth, Bruce D.,Spahr, Mark A.,Ramharack, Randy

, p. 4827 - 4845 (2007/10/03)

Compounds of the general structure A and B were investigated for their activity as lipoprotein(a), [Lp(a)], assembly (coupling) inhibitors. SAR around the amino acid derivatives (structure A) gave compound 14-6 as a potent coupling inhibitor. Oral dosing

Phenyl glycine compounds and methods of treating atherosclerosis and restenosis

-

, (2008/06/13)

The present invention provides compounds having the Formula I The present invention also provides methods of treating atherosclerosis, coronary heart disease, and restenosis using the compounds of Formula I, and pharmaceutical compositions comprising the

Alkylation of 2,6-Di-tert-butylphenol with Ethyl Bromoacetate

Titova, T. F.,Krysin, A. P.

, p. 61 - 63 (2007/10/03)

The ratio of C- and O-alkylation products in the reactions of potassium and sodium 2,6-di-tert-butylphenoxides with ethyl bromoacetate is determined by the nature of the ester group, alkali metal, and solvent.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 6386-40-9